AIMOVIG vs YARTEMLEA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. AIMOVIG and YARTEMLEA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	YARTEMLEA
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	NARSOPLIMAB-WUUG
Manufacturer	Amgen Inc	Omeros Corp
Dosage forms	Injectable, Solution	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	—	Thrombotic Microangiopathies

aimovig yartemlea

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

ERENUMAB-AOOE

NARSOPLIMAB-WUUG

Manufacturer

Amgen Inc

Omeros Corp

Dosage forms

Injectable, Solution

Injectable

Drug class

—

Boxed warning

None

Treats

—

Thrombotic Microangiopathies

Frequently asked questions

What is the difference between Aimovig and Yartemlea?

Aimovig contains Erenumab-Aooe, while Yartemlea contains Narsoplimab-Wuug — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.